Brighter M&A Outlook Prompts Poison Pill Reevaluations | McDermott

COVERAGE

Brighter M&A Outlook Prompts Poison Pill Reevaluations

December 13, 2024

Read time: 2 min

Jon B. Dubrow

Partner

Washington, DC

You may also like